v3.26.1
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 23, 2025
Aug. 01, 2025
Apr. 22, 2025
Mar. 31, 2025
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2026
Mar. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting [Line Items]                        
Revenues, net         $ 3,214,991     $ 18,983,787 $ 22,853 $ 10,297,778 $ 1,930,291
Cost of revenue         (3,201,338)     (18,882,718) (7,374) (10,171,937) (1,898,122)
Gross profit         13,653     101,069 15,479 125,841 32,169
Operating expenses         (1,337,791)   (752,677)   (3,417,780) (2,270,435) (4,419,331) (6,425,572)
Loss from operations         (1,324,138)   (752,677)   (3,316,711) (2,254,956) (5,198,364) (10,863,015)
Fair value variation         (14,131,150)     (31,633,746) 2,024,465 (82,844)
Other income         944   394,588   77,046 403,635 474,954 532,593
Other expense                 (7,323) (50,320) (309,121) (665,795)
Net loss from continuing operations         (15,434,637)   (385,556)   (34,860,910) (1,921,805) (4,887,460) (12,178,813)
Operating expenses                     (4,419,331)  
Allowance for credit loss                     (2,098) (3,450,141)
Inventory write-down                     (902,776)  
Loss on acquisition $ (113) $ (1,859,071) $ (45) $ (20,164)   (20,164)   (20,164) (20,210)
Goodwill impairment                     (1,859,184)
Other income                     474,954  
Impairment loss on assets held for sale                     203,973
Loss from investment                 (1,092,169)
Interest expense, net             (7,583)
Gain from discontinued operations [1]                     3,206,078
Net loss         $ (15,434,637) $ (19,426,273) $ (385,556) $ (1,536,249) (34,860,910) $ (1,921,805) (4,890,555) (8,972,735)
Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                 18,983,787   10,298,669  
Cost of revenue                 (18,882,718)   (10,172,828)  
Gross profit                 101,069   125,841  
Operating expenses                 (3,417,780)      
Loss from operations                 (3,316,711)   (5,198,364)  
Fair value variation                 (31,633,746)   2,024,465  
Gain on disposal of subsidiary                 19,824      
Other income                 77,046      
Other expense                 (7,323)   (309,121)  
Net loss from continuing operations                 (34,860,910)   (4,887,460)  
Operating expenses                     (4,419,331)  
Allowance for credit loss                     (2,098)  
Inventory write-down                     (902,776)  
Loss on acquisition                     (20,210)  
Goodwill impairment                     (1,859,184)  
Other income                     474,954  
Homology of Medicine and Food Series [Member] | Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                 1,855,618   6,349,252  
Cost of revenue                 (1,830,086)   (6,278,927)  
Gross profit                 25,532   70,325  
Operating expenses                 (47,537)      
Loss from operations                 (22,005)   48,213  
Fair value variation                    
Gain on disposal of subsidiary                      
Other income                 155      
Other expense                 (8)   (143)  
Net loss from continuing operations                 (21,858)   1,831,211  
Operating expenses                     (20,014)  
Allowance for credit loss                     (2,098)  
Inventory write-down                      
Loss on acquisition                     (20,210)  
Goodwill impairment                     (1,859,071)  
Other income                      
Computing Power Product Series [Member] | Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                 5,010,158   3,804,691  
Cost of revenue                 (4,933,945)   (3,777,292)  
Gross profit                 76,213   27,399  
Operating expenses                 (86,256)      
Loss from operations                 (10,043)   (33,587)  
Fair value variation                    
Gain on disposal of subsidiary                      
Other income                 178      
Other expense                 (13)   (71)  
Net loss from continuing operations                 (9,878)   (33,658)  
Operating expenses                     (60,986)  
Allowance for credit loss                      
Inventory write-down                      
Loss on acquisition                      
Goodwill impairment                      
Other income                      
Maca Product [Member] | Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                 12,118,011   144,726  
Cost of revenue                 (12,118,589)   (116,609)  
Gross profit                 (578)   28,117  
Operating expenses                 (270,238)      
Loss from operations                 (270,816)   (2,481,470)  
Fair value variation                    
Gain on disposal of subsidiary                      
Other income                 1,654      
Other expense                 (90)   (9,125)  
Net loss from continuing operations                 (269,252)   (2,420,360)  
Operating expenses                     (1,606,811)  
Allowance for credit loss                      
Inventory write-down                     (902,776)  
Loss on acquisition                      
Goodwill impairment                      
Other income                     70,235  
Others Unallocated Headquarter Costs [Member] | Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                      
Cost of revenue                 (98)      
Gross profit                 (98)      
Operating expenses                 (3,013,749)      
Loss from operations                 (3,013,847)      
Fair value variation                 (31,633,746)      
Gain on disposal of subsidiary                 19,824      
Other income                 75,059      
Other expense                 (7,212)      
Net loss from continuing operations                 $ (34,559,922)      
Others Headquarter [Member] | Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                      
Cost of revenue                      
Gross profit                      
Loss from operations                     (2,731,520)  
Fair value variation                     2,024,465  
Other expense                     (299,782)  
Net loss from continuing operations                     (602,231)  
Operating expenses                     (2,731,520)  
Allowance for credit loss                      
Inventory write-down                      
Loss on acquisition                      
Goodwill impairment                     (113)  
Other income                     404,719  
Adjustments And Eliminations [Member] | Operating Segments [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                     (891)  
Cost of revenue                     891  
Gross profit                      
Loss from operations                      
Fair value variation                      
Other expense                      
Net loss from continuing operations                      
Operating expenses                      
Allowance for credit loss                      
Inventory write-down                      
Loss on acquisition                      
Goodwill impairment                      
Other income                      
Maca Product Series [Member]                        
Segment Reporting [Line Items]                        
Revenues, net                       1,930,291
Cost of revenue                       (1,898,122)
Gross profit                       32,169
Loss from operations                       (10,863,015)
Other expense                       (665,795)
Operating expenses                       (6,425,572)
Allowance for credit loss                       (3,450,141)
Inventory write-down                       815,498
Other income                       532,593
Impairment loss on assets held for sale                       (203,973)
Fair value variation                       (82,844)
Loss from investment                       (1,092,169)
Interest expense, net                       (7,583)
Gain from discontinued operations                       3,206,078
Net loss                       $ (8,972,735)
[1] On June 7, 2024, the Company sold (i) NuZee Korea Ltd., a company incorporated in Korea, and (ii) NuZee Investment Co., Ltd., a company incorporated in Japan, each of which was a wholly owned subsidiary of the Company.